 | • レポートコード：QYR2104Z1245 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、子宮頸がんのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（パパニコロウ検査、HPV検査、コルポスコピー、子宮頸部生検）、用途別市場規模（病院、がん緩和ケアクリニック、診断センター、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・子宮頸がんの市場動向 ・企業の競争状況、市場シェア ・子宮頸がんの種類別市場規模（パパニコロウ検査、HPV検査、コルポスコピー、子宮頸部生検） ・子宮頸がんの用途別市場規模（病院、がん緩和ケアクリニック、診断センター、薬局） ・子宮頸がんの北米市場規模2016-2027（アメリカ、カナダ） ・子宮頸がんのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・子宮頸がんのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・子宮頸がんの中南米市場規模2016-2027（メキシコ、ブラジル） ・子宮頸がんの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（F. Hoffmann-La Roche、GlaxoSmithKline、Merck、Advaxis Immunotherapies、Bionor Pharma、Dendreon Corporation、Inovio Pharmaceuticals、ISA Pharmaceuticals、Otsuka Pharmaceuticals、Profectus Biosciences、Virometix、Hologic） ・結論 |
Cervical cancer is the abnormal growth of cancerous cells in the tissues of the cervix. Cervical cancer is caused due to uncontrolled division of abnormal or cancerous cell growth in cervix region (lower uterus part) that leads to vagina in female reproductive tract.
North America accounted for the largest share of the global market, followed by Europe.
Market Analysis and Insights: Global Cervical Cancer Market
The global Cervical Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cervical Cancer market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cervical Cancer market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cervical Cancer market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cervical Cancer market.
Global Cervical Cancer Scope and Market Size
Cervical Cancer market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cervical Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Pap Testing
HPV Testing
Colposcopy
Cervical Biopsies
Segment by Application
Hospitals
Cancer Palliative Care Clinics
Diagnostic Centers
Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
F. Hoffmann-La Roche
GlaxoSmithKline
Merck
Advaxis Immunotherapies
Bionor Pharma
Dendreon Corporation
Inovio Pharmaceuticals
ISA Pharmaceuticals
Otsuka Pharmaceuticals
Advaxis Immunotherapies
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cervical Cancer Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Pap Testing
1.2.3 HPV Testing
1.2.4 Colposcopy
1.2.5 Cervical Biopsies
1.3 Market by Application
1.3.1 Global Cervical Cancer Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Cancer Palliative Care Clinics
1.3.4 Diagnostic Centers
1.3.5 Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cervical Cancer Market Perspective (2016-2027)
2.2 Cervical Cancer Growth Trends by Regions
2.2.1 Cervical Cancer Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cervical Cancer Historic Market Share by Regions (2016-2021)
2.2.3 Cervical Cancer Forecasted Market Size by Regions (2022-2027)
2.3 Cervical Cancer Industry Dynamic
2.3.1 Cervical Cancer Market Trends
2.3.2 Cervical Cancer Market Drivers
2.3.3 Cervical Cancer Market Challenges
2.3.4 Cervical Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cervical Cancer Players by Revenue
3.1.1 Global Top Cervical Cancer Players by Revenue (2016-2021)
3.1.2 Global Cervical Cancer Revenue Market Share by Players (2016-2021)
3.2 Global Cervical Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cervical Cancer Revenue
3.4 Global Cervical Cancer Market Concentration Ratio
3.4.1 Global Cervical Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cervical Cancer Revenue in 2020
3.5 Cervical Cancer Key Players Head office and Area Served
3.6 Key Players Cervical Cancer Product Solution and Service
3.7 Date of Enter into Cervical Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cervical Cancer Breakdown Data by Type
4.1 Global Cervical Cancer Historic Market Size by Type (2016-2021)
4.2 Global Cervical Cancer Forecasted Market Size by Type (2022-2027)
5 Cervical Cancer Breakdown Data by Application
5.1 Global Cervical Cancer Historic Market Size by Application (2016-2021)
5.2 Global Cervical Cancer Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cervical Cancer Market Size (2016-2027)
6.2 North America Cervical Cancer Market Size by Type
6.2.1 North America Cervical Cancer Market Size by Type (2016-2021)
6.2.2 North America Cervical Cancer Market Size by Type (2022-2027)
6.2.3 North America Cervical Cancer Market Size by Type (2016-2027)
6.3 North America Cervical Cancer Market Size by Application
6.3.1 North America Cervical Cancer Market Size by Application (2016-2021)
6.3.2 North America Cervical Cancer Market Size by Application (2022-2027)
6.3.3 North America Cervical Cancer Market Size by Application (2016-2027)
6.4 North America Cervical Cancer Market Size by Country
6.4.1 North America Cervical Cancer Market Size by Country (2016-2021)
6.4.2 North America Cervical Cancer Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Cervical Cancer Market Size (2016-2027)
7.2 Europe Cervical Cancer Market Size by Type
7.2.1 Europe Cervical Cancer Market Size by Type (2016-2021)
7.2.2 Europe Cervical Cancer Market Size by Type (2022-2027)
7.2.3 Europe Cervical Cancer Market Size by Type (2016-2027)
7.3 Europe Cervical Cancer Market Size by Application
7.3.1 Europe Cervical Cancer Market Size by Application (2016-2021)
7.3.2 Europe Cervical Cancer Market Size by Application (2022-2027)
7.3.3 Europe Cervical Cancer Market Size by Application (2016-2027)
7.4 Europe Cervical Cancer Market Size by Country
7.4.1 Europe Cervical Cancer Market Size by Country (2016-2021)
7.4.2 Europe Cervical Cancer Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cervical Cancer Market Size (2016-2027)
8.2 Asia-Pacific Cervical Cancer Market Size by Type
8.2.1 Asia-Pacific Cervical Cancer Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cervical Cancer Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cervical Cancer Market Size by Type (2016-2027)
8.3 Asia-Pacific Cervical Cancer Market Size by Application
8.3.1 Asia-Pacific Cervical Cancer Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cervical Cancer Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cervical Cancer Market Size by Application (2016-2027)
8.4 Asia-Pacific Cervical Cancer Market Size by Region
8.4.1 Asia-Pacific Cervical Cancer Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cervical Cancer Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cervical Cancer Market Size (2016-2027)
9.2 Latin America Cervical Cancer Market Size by Type
9.2.1 Latin America Cervical Cancer Market Size by Type (2016-2021)
9.2.2 Latin America Cervical Cancer Market Size by Type (2022-2027)
9.2.3 Latin America Cervical Cancer Market Size by Type (2016-2027)
9.3 Latin America Cervical Cancer Market Size by Application
9.3.1 Latin America Cervical Cancer Market Size by Application (2016-2021)
9.3.2 Latin America Cervical Cancer Market Size by Application (2022-2027)
9.3.3 Latin America Cervical Cancer Market Size by Application (2016-2027)
9.4 Latin America Cervical Cancer Market Size by Country
9.4.1 Latin America Cervical Cancer Market Size by Country (2016-2021)
9.4.2 Latin America Cervical Cancer Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cervical Cancer Market Size (2016-2027)
10.2 Middle East & Africa Cervical Cancer Market Size by Type
10.2.1 Middle East & Africa Cervical Cancer Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cervical Cancer Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cervical Cancer Market Size by Type (2016-2027)
10.3 Middle East & Africa Cervical Cancer Market Size by Application
10.3.1 Middle East & Africa Cervical Cancer Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cervical Cancer Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cervical Cancer Market Size by Application (2016-2027)
10.4 Middle East & Africa Cervical Cancer Market Size by Country
10.4.1 Middle East & Africa Cervical Cancer Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cervical Cancer Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Details
11.1.2 F. Hoffmann-La Roche Business Overview
11.1.3 F. Hoffmann-La Roche Cervical Cancer Introduction
11.1.4 F. Hoffmann-La Roche Revenue in Cervical Cancer Business (2016-2021)
11.1.5 F. Hoffmann-La Roche Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Cervical Cancer Introduction
11.2.4 GlaxoSmithKline Revenue in Cervical Cancer Business (2016-2021)
11.2.5 GlaxoSmithKline Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Cervical Cancer Introduction
11.3.4 Merck Revenue in Cervical Cancer Business (2016-2021)
11.3.5 Merck Recent Development
11.4 Advaxis Immunotherapies
11.4.1 Advaxis Immunotherapies Company Details
11.4.2 Advaxis Immunotherapies Business Overview
11.4.3 Advaxis Immunotherapies Cervical Cancer Introduction
11.4.4 Advaxis Immunotherapies Revenue in Cervical Cancer Business (2016-2021)
11.4.5 Advaxis Immunotherapies Recent Development
11.5 Bionor Pharma
11.5.1 Bionor Pharma Company Details
11.5.2 Bionor Pharma Business Overview
11.5.3 Bionor Pharma Cervical Cancer Introduction
11.5.4 Bionor Pharma Revenue in Cervical Cancer Business (2016-2021)
11.5.5 Bionor Pharma Recent Development
11.6 Dendreon Corporation
11.6.1 Dendreon Corporation Company Details
11.6.2 Dendreon Corporation Business Overview
11.6.3 Dendreon Corporation Cervical Cancer Introduction
11.6.4 Dendreon Corporation Revenue in Cervical Cancer Business (2016-2021)
11.6.5 Dendreon Corporation Recent Development
11.7 Inovio Pharmaceuticals
11.7.1 Inovio Pharmaceuticals Company Details
11.7.2 Inovio Pharmaceuticals Business Overview
11.7.3 Inovio Pharmaceuticals Cervical Cancer Introduction
11.7.4 Inovio Pharmaceuticals Revenue in Cervical Cancer Business (2016-2021)
11.7.5 Inovio Pharmaceuticals Recent Development
11.8 ISA Pharmaceuticals
11.8.1 ISA Pharmaceuticals Company Details
11.8.2 ISA Pharmaceuticals Business Overview
11.8.3 ISA Pharmaceuticals Cervical Cancer Introduction
11.8.4 ISA Pharmaceuticals Revenue in Cervical Cancer Business (2016-2021)
11.8.5 ISA Pharmaceuticals Recent Development
11.9 Otsuka Pharmaceuticals
11.9.1 Otsuka Pharmaceuticals Company Details
11.9.2 Otsuka Pharmaceuticals Business Overview
11.9.3 Otsuka Pharmaceuticals Cervical Cancer Introduction
11.9.4 Otsuka Pharmaceuticals Revenue in Cervical Cancer Business (2016-2021)
11.9.5 Otsuka Pharmaceuticals Recent Development
11.10 Profectus Biosciences
11.10.1 Profectus Biosciences Company Details
11.10.2 Profectus Biosciences Business Overview
11.10.3 Profectus Biosciences Cervical Cancer Introduction
11.10.4 Profectus Biosciences Revenue in Cervical Cancer Business (2016-2021)
11.10.5 Profectus Biosciences Recent Development
11.11 Virometix
11.11.1 Virometix Company Details
11.11.2 Virometix Business Overview
11.11.3 Virometix Cervical Cancer Introduction
11.11.4 Virometix Revenue in Cervical Cancer Business (2016-2021)
11.11.5 Virometix Recent Development
11.12 Hologic
11.12.1 Hologic Company Details
11.12.2 Hologic Business Overview
11.12.3 Hologic Cervical Cancer Introduction
11.12.4 Hologic Revenue in Cervical Cancer Business (2016-2021)
11.12.5 Hologic Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cervical Cancer Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Pap Testing
Table 3. Key Players of HPV Testing
Table 4. Key Players of Colposcopy
Table 5. Key Players of Cervical Biopsies
Table 6. Global Cervical Cancer Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Cervical Cancer Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Cervical Cancer Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Cervical Cancer Market Share by Regions (2016-2021)
Table 10. Global Cervical Cancer Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Cervical Cancer Market Share by Regions (2022-2027)
Table 12. Cervical Cancer Market Trends
Table 13. Cervical Cancer Market Drivers
Table 14. Cervical Cancer Market Challenges
Table 15. Cervical Cancer Market Restraints
Table 16. Global Cervical Cancer Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Cervical Cancer Market Share by Players (2016-2021)
Table 18. Global Top Cervical Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cervical Cancer as of 2020)
Table 19. Ranking of Global Top Cervical Cancer Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Cervical Cancer Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Cervical Cancer Product Solution and Service
Table 23. Date of Enter into Cervical Cancer Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cervical Cancer Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Cervical Cancer Revenue Market Share by Type (2016-2021)
Table 27. Global Cervical Cancer Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Cervical Cancer Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Cervical Cancer Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Cervical Cancer Revenue Market Share by Application (2016-2021)
Table 31. Global Cervical Cancer Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Cervical Cancer Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Cervical Cancer Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Cervical Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Cervical Cancer Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Cervical Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Cervical Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Cervical Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Cervical Cancer Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Cervical Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Cervical Cancer Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Cervical Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Cervical Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Cervical Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Cervical Cancer Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Cervical Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cervical Cancer Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Cervical Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Cervical Cancer Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Cervical Cancer Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Cervical Cancer Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Cervical Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Cervical Cancer Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Cervical Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Cervical Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Cervical Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Cervical Cancer Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Cervical Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cervical Cancer Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Cervical Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Cervical Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Cervical Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 63. F. Hoffmann-La Roche Company Details
Table 64. F. Hoffmann-La Roche Business Overview
Table 65. F. Hoffmann-La Roche Cervical Cancer Product
Table 66. F. Hoffmann-La Roche Revenue in Cervical Cancer Business (2016-2021) & (US$ Million)
Table 67. F. Hoffmann-La Roche Recent Development
Table 68. GlaxoSmithKline Company Details
Table 69. GlaxoSmithKline Business Overview
Table 70. GlaxoSmithKline Cervical Cancer Product
Table 71. GlaxoSmithKline Revenue in Cervical Cancer Business (2016-2021) & (US$ Million)
Table 72. GlaxoSmithKline Recent Development
Table 73. Merck Company Details
Table 74. Merck Business Overview
Table 75. Merck Cervical Cancer Product
Table 76. Merck Revenue in Cervical Cancer Business (2016-2021) & (US$ Million)
Table 77. Merck Recent Development
Table 78. Advaxis Immunotherapies Company Details
Table 79. Advaxis Immunotherapies Business Overview
Table 80. Advaxis Immunotherapies Cervical Cancer Product
Table 81. Advaxis Immunotherapies Revenue in Cervical Cancer Business (2016-2021) & (US$ Million)
Table 82. Advaxis Immunotherapies Recent Development
Table 83. Bionor Pharma Company Details
Table 84. Bionor Pharma Business Overview
Table 85. Bionor Pharma Cervical Cancer Product
Table 86. Bionor Pharma Revenue in Cervical Cancer Business (2016-2021) & (US$ Million)
Table 87. Bionor Pharma Recent Development
Table 88. Dendreon Corporation Company Details
Table 89. Dendreon Corporation Business Overview
Table 90. Dendreon Corporation Cervical Cancer Product
Table 91. Dendreon Corporation Revenue in Cervical Cancer Business (2016-2021) & (US$ Million)
Table 92. Dendreon Corporation Recent Development
Table 93. Inovio Pharmaceuticals Company Details
Table 94. Inovio Pharmaceuticals Business Overview
Table 95. Inovio Pharmaceuticals Cervical Cancer Product
Table 96. Inovio Pharmaceuticals Revenue in Cervical Cancer Business (2016-2021) & (US$ Million)
Table 97. Inovio Pharmaceuticals Recent Development
Table 98. ISA Pharmaceuticals Company Details
Table 99. ISA Pharmaceuticals Business Overview
Table 100. ISA Pharmaceuticals Revenue in Cervical Cancer Business (2016-2021) & (US$ Million)
Table 101. ISA Pharmaceuticals Recent Development
Table 102. Otsuka Pharmaceuticals Company Details
Table 103. Otsuka Pharmaceuticals Business Overview
Table 104. Otsuka Pharmaceuticals Cervical Cancer Product
Table 105. Otsuka Pharmaceuticals Revenue in Cervical Cancer Business (2016-2021) & (US$ Million)
Table 106. Otsuka Pharmaceuticals Recent Development
Table 107. Profectus Biosciences Company Details
Table 108. Profectus Biosciences Business Overview
Table 109. Profectus Biosciences Cervical Cancer Product
Table 110. Profectus Biosciences Revenue in Cervical Cancer Business (2016-2021) & (US$ Million)
Table 111. Profectus Biosciences Recent Development
Table 112. Virometix Company Details
Table 113. Virometix Business Overview
Table 114. Virometix Cervical Cancer Product
Table 115. Virometix Revenue in Cervical Cancer Business (2016-2021) & (US$ Million)
Table 116. Virometix Recent Development
Table 117. Hologic Company Details
Table 118. Hologic Business Overview
Table 119. Hologic Cervical Cancer Product
Table 120. Hologic Revenue in Cervical Cancer Business (2016-2021) & (US$ Million)
Table 121. Hologic Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cervical Cancer Market Share by Type: 2020 VS 2027
Figure 2. Pap Testing Features
Figure 3. HPV Testing Features
Figure 4. Colposcopy Features
Figure 5. Cervical Biopsies Features
Figure 6. Global Cervical Cancer Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Cancer Palliative Care Clinics Case Studies
Figure 9. Diagnostic Centers Case Studies
Figure 10. Pharmacies Case Studies
Figure 11. Cervical Cancer Report Years Considered
Figure 12. Global Cervical Cancer Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Cervical Cancer Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Cervical Cancer Market Share by Regions: 2020 VS 2027
Figure 15. Global Cervical Cancer Market Share by Regions (2022-2027)
Figure 16. Global Cervical Cancer Market Share by Players in 2020
Figure 17. Global Top Cervical Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cervical Cancer as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Cervical Cancer Revenue in 2020
Figure 19. Global Cervical Cancer Revenue Market Share by Type (2016-2021)
Figure 20. Global Cervical Cancer Revenue Market Share by Type (2022-2027)
Figure 21. North America Cervical Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Cervical Cancer Market Share by Type (2016-2027)
Figure 23. North America Cervical Cancer Market Share by Application (2016-2027)
Figure 24. North America Cervical Cancer Market Share by Country (2016-2027)
Figure 25. United States Cervical Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Cervical Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Cervical Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Cervical Cancer Market Share by Type (2016-2027)
Figure 29. Europe Cervical Cancer Market Share by Application (2016-2027)
Figure 30. Europe Cervical Cancer Market Share by Country (2016-2027)
Figure 31. Germany Cervical Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Cervical Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Cervical Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Cervical Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Cervical Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Cervical Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Cervical Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Cervical Cancer Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Cervical Cancer Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Cervical Cancer Market Share by Region (2016-2027)
Figure 41. China Cervical Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Cervical Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Cervical Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Cervical Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Cervical Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Cervical Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Cervical Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Cervical Cancer Market Share by Type (2016-2027)
Figure 49. Latin America Cervical Cancer Market Share by Application (2016-2027)
Figure 50. Latin America Cervical Cancer Market Share by Country (2016-2027)
Figure 51. Mexico Cervical Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Cervical Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Cervical Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Cervical Cancer Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Cervical Cancer Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Cervical Cancer Market Share by Country (2016-2027)
Figure 57. Turkey Cervical Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Cervical Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Cervical Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. F. Hoffmann-La Roche Revenue Growth Rate in Cervical Cancer Business (2016-2021)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Cervical Cancer Business (2016-2021)
Figure 62. Merck Revenue Growth Rate in Cervical Cancer Business (2016-2021)
Figure 63. Advaxis Immunotherapies Revenue Growth Rate in Cervical Cancer Business (2016-2021)
Figure 64. Bionor Pharma Revenue Growth Rate in Cervical Cancer Business (2016-2021)
Figure 65. Dendreon Corporation Revenue Growth Rate in Cervical Cancer Business (2016-2021)
Figure 66. Inovio Pharmaceuticals Revenue Growth Rate in Cervical Cancer Business (2016-2021)
Figure 67. ISA Pharmaceuticals Revenue Growth Rate in Cervical Cancer Business (2016-2021)
Figure 68. Otsuka Pharmaceuticals Revenue Growth Rate in Cervical Cancer Business (2016-2021)
Figure 69. Profectus Biosciences Revenue Growth Rate in Cervical Cancer Business (2016-2021)
Figure 70. Virometix Revenue Growth Rate in Cervical Cancer Business (2016-2021)
Figure 71. Hologic Revenue Growth Rate in Cervical Cancer Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
世界の子宮頸がん診断検査市場規模・現状・予測（2021年-2027年） Cervical cancer is the abnormal growth of cancerous cells in the tissues of the cervix. Cervical cancer is caused due to uncontrolled division of abnormal or cancerous cell growth in cervix region (lower uterus part) that leads to vagina in female reproductive tract. North America accounted for the …- 世界の子宮頸がん市場規模・現状・予測（2021年-2027年） Cervical cancer is the abnormal growth of cancerous cells in the tissues of the cervix. Cervical cancer is caused due to uncontrolled division of abnormal or cancerous cell growth in cervix region (lower uterus part) that leads to vagina in female reproductive tract. North America accounted for the …
- 世界の子宮頸がん診断検査市場規模・現状・予測（2021年-2027年） Cervical cancer is a cancer arising from the cervix. It is due to the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Market Analysis and Insights: Global Cervical Cancer Diagnostic Tests Market The global Cervical Cancer Diagnostic Tests market size is…
- 世界の子宮頸がんスクリーニング市場規模・現状・予測（2021年-2027年） Cervical screening is the process of recognizing and expelling abnormal tissue or cells in the cervix before precancerous cervical lesions or cervical malignancy develops. Continuous growth of cancer‘s impact on Public Health is the primary factor that drives the Cervical Cancer Screening Market. Th…
- 世界の子宮頸がん治療法・診断市場規模・現状・予測（2021年-2027年） Therapies and Diagnostics for Cervical Cancer refers to a series of methods and medical devices that can be used for the diagnosis and treatment of cervical cancer. The factors that are driving the cervical cancer market are HPV infection, women having many sexual partners, women getting sexually ac…